Olanzapine for weight gain in children undergoing chemotherapy for solid-organ malignancies: An investigator-initiated, open-label, multicenter, phase III randomized controlled trial (SNOWMAN).
Shubham Sahni, Sameer Bakhshi, S Ganguly, Archana Sasi et autres
10053 Background: Children receiving intensive chemotherapy for solid-organ malignancies frequently experience deterioration in nutritional status. Olanzapine improves nutritional outcomes in adults with advanced cancer and is guideline-endorsed. Its use in pediatric oncology has been limited by safety concerns and lack of robust …
in (code pays fourni par la source)
0 citations
Journal of Clinical Oncology